^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    CRY1 rs1056560

    i
    Other names: CRY1, Cryptochrome Circadian Regulator 1, Cryptochrome 1 (Photolyase-Like), Cryptochrome Circadian Clock 1, Cryptochrome-1, PHLL1, DSPD
    Entrez ID:
    1407
    Related biomarkers:
    Mutation
    almost4years
    [VIRTUAL] Single nucleotide polymorphism (SNP) analysis identifies potential prognostic and predictive biomarker in patients (pts) with metastatic colorectal cancer (mCRC) treated with regorafenib in the phase III CORRECT trial (ESMO 2020)
    Funding: Bayer. Clinical trial identification: NCT01103323.
    Clinical • P3 data
    |
    VEGFA (Vascular endothelial growth factor A)
    |
    CRY1 rs1056560
    |
    Stivarga (regorafenib)